Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Gilead
Biotech

Gilead to buy PepStar’s oral IL-23 drug for $1.3B upfront

The deal positions Gilead as a would-be challenger to Johnson & Johnson’s Icotyde across a range of inflammatory diseases.
Nick Paul Taylor Oct 23, 2026 11:20am
Boehringer Ingelheim booth at AACR 2026

ESMO: Boehringer builds case for late-phase rival to Imdelltra

Oct 23, 2026 10:30am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
lightning

Bolt strikes Prana reverse merger alongside $120M financing

Oct 23, 2026 10:21am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
cancer cell split mitosis breast cancer metastasize

ESMO: Why Zentalis is already dreaming of launching WEE1 drug

Oct 23, 2026 10:15am